skip to main content
Show Results with:

9 results  for Everything in this catalogue

Result Number Material Type Add to My Shelf Action Record Details and Options
1
Material Type:
Article
Add to My workspace

Pembrolizumab-triggered Uveitis: An Additional Surrogate Marker for Responders in Melanoma Immunotherapy?

Diem, Stefan et al.

Journal of immunotherapy: official journal of the Society for Biological Therapy. Volume 39:Issue 9 (2016, November/December) -- Lippincott Williams & Wilkins

Online access

2
Material Type:
Article
Add to My workspace

Pembrolizumab-triggered Uveitis: An Additional Surrogate Marker for Responders in Melanoma Immunotherapy?

Diem, Stefan et al.

Journal of immunotherapy: official journal of the Society for Biological Therapy. Volume 39:Issue 9 (2016, November); pp 379-382 -- Lippincott Williams & Wilkins

Online access

3
Material Type:
Article
Add to My workspace

Vogt-Koyanagi-Harada-like Syndrome After CTLA-4 Inhibition With Ipilimumab for Metastatic Melanoma

Crosson, Jason N. et al.

Journal of immunotherapy: official journal of the Society for Biological Therapy. Volume 38:Issue 2 (2015, February/March) -- Lippincott Williams & Wilkins

Online access

4
Material Type:
Article
Add to My workspace

Vogt-Koyanagi-Harada-like Syndrome After CTLA-4 Inhibition With Ipilimumab for Metastatic Melanoma

Crosson, Jason N. et al.

Journal of immunotherapy: official journal of the Society for Biological Therapy. Volume 38:Issue 2 (2015, February); pp 80-84 -- Lippincott Williams & Wilkins

Online access

5
Material Type:
Article
Add to My workspace

CHECKPOINT INHIBITOR IMMUNE THERAPY: Systemic Indications and Ophthalmic Side Effects

Dalvin, Lauren A. et al.

Retina. Volume 38:Issue 6 (2018) -- Lippincott, Williams & Wilkins

Online access

6
Material Type:
Article
Add to My workspace

PEMBROLIZUMAB ADMINISTRATION ASSOCIATED WITH POSTERIOR UVEITIS

Aaberg, Michael T.; Aaberg, Thomas M.

Retinal cases & brief reports. Volume 11:Issues 4 (2017) -- Lippincott Williams & Wilkins

Online access

7
Material Type:
Article
Add to My workspace

Vogt-Koyanagi-Harada–like Syndrome Complicating Pembrolizumab Treatment for Metastatic Melanoma

Bricout, Marion et al.

Journal of immunotherapy: official journal of the Society for Biological Therapy. Volume 40:Issue 2 (2017, February); pp 77-82 -- Lippincott Williams & Wilkins

Online access

8
Material Type:
Article
Add to My workspace

Vogt-Koyanagi-Harada–like Syndrome Complicating Pembrolizumab Treatment for Metastatic Melanoma

Bricout, Marion et al.

Journal of immunotherapy: official journal of the Society for Biological Therapy. Volume 40:Issue 2 (2017, February/March) -- Lippincott Williams & Wilkins

Online access

9
Material Type:
Article
Add to My workspace

HLA‐DRB1*04:05 in two cases of Vogt–Koyanagi–Harada disease‐like uveitis developing from an advanced melanoma patient treated by sequential administration of nivolumab and dabrafenib/trametinib therapy

Fujimura, Taku et al.

The journal of dermatology. Volume 45:Issue 6 (2018); pp 735-737 -- [Wiley-Blackwell]

Online access

9 results  for Everything in this catalogue

Refine Search Results

Refine my results

Access Options 

  1. Request to Reading Room  (6)
  2. Purchase a copy  (3)
  3. Refine further open sub menu

Creation date 

From To

Searching Remote Databases, Please Wait